Nephrotic syndrome trials in Poland

5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

  Where

  Lodz, Opole, Poznan

  Age

  16 years to 75 years

  People

  84 worldwide

  Run by

  Sanofi

  See details and how to joinNCT06500702
• Phase 3Taking people
  BOOSTER – Multicenter, Open Label, Randomized Control Phase III Trial Comparing the Efficacy and Safety of Two Rituximab Regimens in Maintenance Therapy for Relapsing Nephrotic Syndrome Due to Podocytopathies in Adults. (B cell Depletion Therapy to Improve Outcomes of Relapsing STERoid-sensitive Podocytopathies in Adults – BOOSTER trial)

  Where

  Bydgoszcz, Katowice, Kielce, Lodz, Lublin, Olsztyn, Opole, Poznan, Rzeszów, Szczecin, Warsaw, Wroclaw

  Age

  18 years and over

  People

  70

  Run by

  Medical University Of Lodz

  See details and how to join2023-509755-13-00
• Phase 2Taking people
  Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

  Where

  Cracow

  Age

  1 year to 17 years

  People

  67 worldwide

  Run by

  Travere Therapeutics, Inc.

  See details and how to joinNCT05003986 · EU 2023-505497-14-00
• Phase 3Taking people
  Early rituximab treatment in children with idiopathic nephrotic syndrome Eng. ERICONS - Early RITUXIMAB in Childhood Onset Nephrotic Syndrome

  Where

  Bialystok, Gdansk, Krakow, Lodz, Lublin, Poznań, Warszawa, Wrocław, Zabrze

  Age

  Up to 17 years

  People

  60

  Run by

  Medical University Of Gdansk

  See details and how to join2024-515058-26-00
• Phase 3Taking people
  Ketoanalogues for Muscle Mass Loss in Nephrotic Syndrome

  Where

  Cracow, Gdansk, Grodzisk Mazowiecki, Lodz, Radom, Rzeszów, Warsaw, Wroclaw

  Age

  18 years and over

  People

  150

  Run by

  Military Institute od Medicine National Research Institute

  See details and how to joinNCT05716880 · EU 2024-517880-22-00